User contributions for JDoerfler
Appearance
26 July 2024
- 10:2510:25, 26 July 2024 diff hist +47 Ferreira et al. (2004): Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial No edit summary
- 10:1010:10, 26 July 2024 diff hist +13 Fallahi et al. (2013): Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? No edit summary
- 10:0810:08, 26 July 2024 diff hist +32 Delanian et al. (2003): Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis No edit summary
- 10:0710:07, 26 July 2024 diff hist +18 Azizi et al. (2015): Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis No edit summary
- 10:0610:06, 26 July 2024 diff hist +26 Argyriou et al. (2006): Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation No edit summary
- 10:0410:04, 26 July 2024 diff hist +23 Argyriou et al. (2006): A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results No edit summary
- 10:0310:03, 26 July 2024 diff hist +35 Afonseca et al. (2013): Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial No edit summary
- 09:5309:53, 26 July 2024 diff hist +66 Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology No edit summary
- 09:5009:50, 26 July 2024 diff hist +504 Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology No edit summary
- 09:4909:49, 26 July 2024 diff hist +36 Muecke et al. (2014): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization No edit summary
- 09:4709:47, 26 July 2024 diff hist +36 Muecke et al. (2013): Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology-a subgroup analysis of a multicenter, phase III trial No edit summary
- 09:4509:45, 26 July 2024 diff hist +36 Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology No edit summary
- 09:4309:43, 26 July 2024 diff hist +48 Mix et al. (2015): Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck No edit summary
- 09:4109:41, 26 July 2024 diff hist +46 Karp et al. (2012): Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 No edit summary
- 09:3709:37, 26 July 2024 diff hist +26 Jahangard-Rafsanjani et al. (2013): The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial No edit summary
- 09:3609:36, 26 July 2024 diff hist +74 Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial No edit summary
- 09:3409:34, 26 July 2024 diff hist +12 Büntzel et al. (2010): Selenium Substitution During Radiotherapy of Solid Tumours - Laboratory Data from Two Observation Studies in Gynaecological and Head and Neck Cancer Patients No edit summary
- 09:3309:33, 26 July 2024 diff hist −15 Büntzel et al. (2010): Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients No edit summary
- 09:3309:33, 26 July 2024 diff hist +6 Publication: Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients No edit summary
- 09:3209:32, 26 July 2024 diff hist −15 Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients No edit summary
- 09:3109:31, 26 July 2024 diff hist −1 Stratton et al. (2010): Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer No edit summary
- 09:3109:31, 26 July 2024 diff hist −14 Stratton et al. (2010): Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer No edit summary
- 09:3009:30, 26 July 2024 diff hist +41 Laali et al. (2020): Effect of Selenium on Incidence and Severity of Mucositis during Radiotherapy in Patients with Head and Neck Cancer No edit summary
- 09:2809:28, 26 July 2024 diff hist +21 Büntzel et al. (2010): Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients No edit summary
- 09:2709:27, 26 July 2024 diff hist +40 Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients No edit summary
- 09:2509:25, 26 July 2024 diff hist +88 Stratton et al. (2010): Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer No edit summary
25 July 2024
- 12:2712:27, 25 July 2024 diff hist 0 Kirste et al. (2011): Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial No edit summary
23 July 2024
- 12:2812:28, 23 July 2024 diff hist −1 Kraft et al. (2012): L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial No edit summary
- 12:2812:28, 23 July 2024 diff hist +10,517 N Kraft et al. (2012): L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial Created page with "{{Reference |Reference=Publication: L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial }} {{Study Note}} =Brief summary= This study included 72 patients with advanced pancreatic cancer who were randomly and fairly evenly divided into two groups. One group received the carnitine and the other group the placebo. The authors investigated the influence of carnitine on the weight caused by the disease, as well as the influence..."
- 12:0912:09, 23 July 2024 diff hist +1,729 N Publication: L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial Created page with "{{Publication |Title=L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial |Topic=Carnitine |Author=Kraft, M; Kraft, K; Gärtner, S; Mayerle, J; Simon, P; Weber, E; Schütte, K; Stieler, J; Koula-Jenik, H; Holzhauer, P; Gröber, U; Engel, G; Müller, C; Feng, YS; Aghdassi, A; Nitsche, C; Malfertheiner, P; Patrzyk, M; Kohlmann, T; Lerch, MM |Year=2012 |Journal=Deutsche Zeitschrift für Onkologie |DOI=http://www.nutritionj.com/..." current
- 09:4709:47, 23 July 2024 diff hist +391 Koyama et al. (2017): Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients No edit summary
- 09:4309:43, 23 July 2024 diff hist +3,257 Koyama et al. (2017): Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients No edit summary
- 09:3009:30, 23 July 2024 diff hist +3,583 N Koyama et al. (2017): Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients Created page with "{{Reference |Reference=Publication: Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients }} {{Study Note}} =Brief summary= The study investigated the influence of carnitine on the inflammatory and insulin response in patients following surgery for gastric or colorectal cancer. Eight patients were randomly assigned to the control group, who received the usual..."
- 09:2709:27, 23 July 2024 diff hist +1,771 N Publication: Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients Created page with "{{Publication |Title=Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients |Topic=Carnitine |Author=Koyama Y; Moro K; Nakano M; Miura K; Nagahashi M; Kosugi S-i; Tsuchida J; Ikarashi M; Nakajima M; Ichikawa H; Hanyu T; Shimada Y; Sakata J; Kameyama H; Kobayashi T; Wakai T |Year=2017 |Journal=Journal of clinical medicine research |DOI=https://doi.org/10.14740/j..." current
- 09:0109:01, 23 July 2024 diff hist −16 Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy No edit summary
- 09:0109:01, 23 July 2024 diff hist +697 Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy No edit summary
- 08:4908:49, 23 July 2024 diff hist +118 Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy No edit summary
- 08:4408:44, 23 July 2024 diff hist +397 Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy No edit summary
- 08:4008:40, 23 July 2024 diff hist +865 Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy No edit summary
- 08:2908:29, 23 July 2024 diff hist +5,489 Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy No edit summary
22 July 2024
- 12:2512:25, 22 July 2024 diff hist +4,172 N Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy Created page with "{{Reference |Reference=Publication: Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy }} {{Study Note}} =Brief summary= This large-scale study, initially involving 409 breast cancer patients, focused primarily on the effect of carnitine on peripheral neuropathy (an increased toxicity in the brain that negatively affects all functions of the body) caused..."
- 12:2212:22, 22 July 2024 diff hist +9 Publication: Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy No edit summary current
- 12:2112:21, 22 July 2024 diff hist 0 Publication: Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy No edit summary
- 12:1212:12, 22 July 2024 diff hist +2,447 N Publication: Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy Created page with "{{Publication |Title=Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy |Topic=Carnitine |Author=Hershman, DL; Unger, JM; Crew, KD; Minasian, LM; Awad, D; Moinpour, CM; Hansen, L; Lew, DL; Greenlee, H; Fehrenbacher, L; Wade, JL; Wong, SF; Hortobagyi, GN; Meyskens, FL; Albain, KS |Year=2013 |Journal=Journal of clinical oncology: official journal of the Am..."
- 11:5211:52, 22 July 2024 diff hist 0 Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary
- 11:5011:50, 22 July 2024 diff hist 0 Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary
- 11:4811:48, 22 July 2024 diff hist +129 Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary
- 11:4411:44, 22 July 2024 diff hist +65 Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary
- 11:4111:41, 22 July 2024 diff hist +316 Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary
- 11:3811:38, 22 July 2024 diff hist +6,386 Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary